Sonnet Biotherapeutics, Inc. announced it raised $750,000 in an initial filing from an offering of $750,000

May 14, 2019•over 6 years ago

Amount Raised

$750,000

Round Type

seed

PrincetonHealthcare

Company Information

Company

Sonnet BioTherapeutics Holdings

Location

100 OVERLOOK CENTER

Princeton, West Virginia, United States

About

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage company developing targeted immunotherapeutic drugs.

5 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech